Search

    Bio Vitos Pharma AB

    BIOVIT SE0009320278

    ICB 2010 : Health Care / Health Care
    Sweden 171 65
    SE-AB Solna Nanna Svartz väg 4

    Registration Number 556811-5272

    Bio Vitos Pharma AB Formelry Hemcheck Sweden AB is a Sweden based medical technology company. It is developing a product addressing the issue of hemolyzed blood samples.

    Founded 2010
    Employees 2
    https://www.hemcheck.com

    Previous Name(s):
    Lagrummet nr 1833 Aktiebolag
    Hemcheck Sweden AB

    Annual Performance 1
    2021 2022 2023 2024 2025
    156% 1% 977% -4% 20%
    Annual Insiders Turnover, USD 2

    1 annual and historical performance metrics are recalculated on a daily basis;
    2 represents the total value of insider transactions (both buying and selling);

    Insider Activity

    Transactions: 13 Insiders: 5

    Person Price Shares Total Published Completed
    Jesper Birgemo
    CEO     		0.00
    SEK     		2,940,209
    Bought     		0
    SEK     		07/12/2023 07/12/2023
    Anna Klevby Dalgaard
    CB     		4.80
    SEK     		10,289
    Bought     		49,387
    SEK     		04/01/2021 04/01/2021
    Hjalmar Didrikson
    DIR     		4.48
    SEK     		111,588
    Bought     		499,914
    SEK     		30/12/2020 30/12/2020
    Joen Averstad
    CEO     		2.84
    SEK     		35,211
    Bought     		99,999
    SEK     		24/09/2019 24/09/2019
    Anna Klevby Dalgaard
    DIR     		2.84
    SEK     		35,211
    Bought     		99,999
    SEK     		24/09/2019 24/09/2019
    Hjalmar Didrikson
    DIR     		2.84
    SEK     		105,578
    Bought     		299,842
    SEK     		24/09/2019 24/09/2019
    Hjalmar Didrikson
    DIR     		5.42
    SEK     		100,000
    Bought     		542,000
    SEK     		20/05/2019 20/05/2019
    Karin Dahllöf
    DIR     		5.42
    SEK     		18,450
    Bought     		99,999
    SEK     		21/05/2019 20/05/2019
    Anna Klevby Dalgaard
    DIR     		7.62
    SEK     		13,000
    Bought     		99,060
    SEK     		01/04/2019 01/04/2019
    Karin Annelie Brolinson
    CEO     		8.05
    SEK     		7,000
    Bought     		56,350
    SEK     		05/06/2018 05/06/2018

    Integrated EOD Stock Data and Insider Transactions Chart

    Sign in or subscribe to include Bio Vitos Pharma AB to your watchlist and receive automatic alerts for upcoming transactions.

    The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

     

    Historical Performance
    1M 3M 6M 1Y 3Y 5Y All Time
    8% -28% -66% -80% -85% -90% -95%
    Last 52W Low 52W High All-Time Low All-Time High β
    0.05 0.05 3.00 0.05 124.23 0.46
    Company Insiders
    Person / Entity Transactions Turnover, USD Average, USD First Last
    Hjalmar Didrikson 6 159,317.53 26,552.92 10/02/2017 30/12/2020
    Anna Klevby Dalgaard 3 27,006.46 9,002.15 01/04/2019 04/01/2021
    Karin Dahllöf 1 10,371.59 10,371.59 20/05/2019 20/05/2019
    Joen Averstad 1 10,305.93 10,305.93 24/09/2019 24/09/2019
    Karin Annelie Brolinson 1 6,418.53 6,418.53 05/06/2018 05/06/2018

    Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

    Stock Advanced Metrics
    Insider Activity Score
    Discipline Index 5
    Delta Correlation subscribe 🔒
    Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

    4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

    5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.